Abstract:Drugs with poor biopharmaceutical performance are the main obstacle to the development and design of medicinal preparations. The anisotropic surface chemistry of different surfaces on the crystal influences its physical and chemical properties, such as solubility, tableting, etc. In this study, the antisolvent crystallization and rapid-cooling crystallization were carried out to tune the crystal habits of ticagrelor (TICA) form II. Different crystal habits of ticagrelor (TICA) form II (TICA-A, TICA-B, TICA-C, TICA-D, and TICA-E) were prepared and evaluated for solubility. The single-crystal diffraction (SXRD) indicated that TICA form II belongs to the triclinic P1 space group with four TICA molecules in the asymmetric unit. The TICA molecules are generated through intermolecular hydrogen bonds along the (010) direction, forming an infinite molecular chain, which are further stacked by hydrogen bonds between hydroxyethoxy side chains, forming molecular circles composed of six TICA molecules along bc directions. Thus, in the case of TICA form II, hydrogen bonds drive growth along one axis (b-axis), which results in the formation of mostly needle-shape crystals. Morphology and face indexation reveals that (001), (010) and (01-1) are the main crystal planes. Powder diffractions showed that five habits have the same crystal structure and different relative intensity of diffraction peak. The solubility of the obtained crystals showed the crystal habits affect their solubility. This work is helpful for studying the mechanism of crystal habit modification and its effect on solubility.

Process Improvement for Synthesis of Ticagrelor

Improved Synthetic Approach to Tenatoprazole

Synthesis technology of 3-n-propyl-2, 4-dihydroxyacetophenone

SYNTHESIS OF TICLOPIDINE HYDROCHLORIDE

Improved Synthesis of Methyl 3-Oxo-2,6,6-trimethylcyclohex-1-ene-1-carboxylate, an A-ring Intermediate for (±)Strigol

Synthesis of 6-bromo-4,4-dimethylthiochroman

Synthesis of 4- (Methylthio) benzeneacetic Acid

Improved Synthesis of 1-[Hexahydrocyclopenta[c]pyrrol-2(1h)-yl]-3-(4-methylbenzenesulfonyl)ure A

Improvement on Synthesis of 2-Chloromethyl-3,5-dimethyl-4-nitropyridine Hydrochloride

Improved Synthesis of 2‐Chloro‐3‐amino‐4‐methylpyridine

Improved process for the synthesis of telaprevir

New Synthesis Process of 2,7-Dimethyl-2,4,6-octatriene-1,8-dial

Synthesis of 6-Aryl-3-(d-glucopentitol-1-yl)-7h-1,2,4-triazolo-[3,4-b][1,3,4]thiadiaz Ines

Improved Synthesis of 2‐Methoxyphenothiazine

Impact of Crystal Habit on Solubility of Ticagrelor

Computer‐directed rational design enhanced the thermostability of carbonyl reductase LsCR for the synthesis of ticagrelor precursor

Protein engineering of carbonyl reductase for asymmetric synthesis of ticagrelor precursor (1S)-2-chloro-1-(3,4-difluorophenyl)ethanol

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide

One-Step Synthesis of 1,3,4-Triaryl-substituted-3,4,5,6-tetrahydropyrimidin-2(1h)-one Derivatives

Design, Synthesis and Pharmacokinetic Study of Deuterated Ticagrelor Derivatives

An Improved Process for Chiron Synthesis of the Atorvastatin Side Chain